False-Negative Tc-99m MIBI Scintigraphy in Histopathologically Proved Recurrent High-Grade Oligodendroglioma

Clinical Nuclear Medicine

Volumn 28, Issue 4, 2003, Pages 299-301

  Goethals, Ingeborg ^b   De Winter, Olivier ^a   Dierckx, Rudi ^a   Annovazzi, Allessio ^a   Signore, Alberto ^a   Van De Wiele, Christophe ^a  

^a Department of Nuclear Medicine ^*

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

False Negative; Oligodendroglioma; Recurrence; SPECT; Tc 99m MIBI

Indexed keywords

GADOLINIUM; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN SCINTISCANNING; CANCER GRADING; CANCER RADIOTHERAPY; CASE REPORT; CELL VIABILITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DRUG DIFFUSION; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; MITOCHONDRION; OLIGODENDROGLIOMA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT PLANNING; TUMOR CELL; TUMOR RECURRENCE; BRAIN TUMOR; LABORATORY DIAGNOSIS; METHODOLOGY; PATHOLOGY; PREDICTION AND FORECASTING; SCINTISCANNING;

ADULT; BRAIN NEOPLASMS; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; NEOPLASM RECURRENCE, LOCAL; OLIGODENDROGLIOMA; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 85047691889     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RLU.0000057555.93082.B5     Document Type: Article

References (12)

1. Chiu M, Kronauge J, Piwnica-Worms D: Effects of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium-99m in cultured mouse fibroblasts. J Nucl Med 34:1949, 1993.
2. Sutter CW, Stadalnik RC: Noncardiac uptake of technetium-99m sestamibi: an updated gamut. Semin Nucl Med 26:135, 1996.
3. Park CH, Kim SM, Zhang JJ, et al: Tc-99m MIBI brain SPECT in the diagnosis of recurrent glioma. Clin Nucl Med 19:57, 1994.
4. Maffioli L, Gasparini M, Chiti A, et al: Clinical role of technetium-99m sestamibi single-photon emission tomography in evaluating pretreated patients with brain tumours. Eur J Nucl Med 23:308, 1996.
5. Soler C, Beauchesne P, Maatougui K, et al: Technetium-99m sestamibi brain single-photon emission tomography for detection of recurrent gliomas after radiation therapy. Eur J Nucl Med 25:1649, 1998.
6. Lamy-Lhullier C, Dubois F, Blond S, et al: [Importance of cerebral tomoscintigraphy using technetium-labeled sestamibi in the differential diagnosis of current tumor vs. radiation necrosis in subtentorial glial tumors in the adult]. Neurochirurgie 45:110, 1999 [in French].
7. Baillet G, Albuquerque L, Chen Q, et al: Evaluation of single-photon emission tomography imaging of supratentorial brain gliomas with technetium-99m sestamibi. Eur J Nucl Med 21:1061, 1994.
8. Staudenherz A, Fazeny B, Marosi C, et al: Does (99m)Tc-Sestamibi in high-grade malignant brain tumors reflect blood-brain barrier damage only? Neuroimage 12:109, 2000.
9. Bagni B, Pinna L, Tamarozzi R, et al: SPET imaging of intracranial tumours with 99Tcm-sestamibi. Nucl Med Commun 16:258, 1995.
10. Bar-Sella P, Front D, Hardoff R, et al: Ultrastructural basis for different pertechnetate uptake patterns by various human brain tumours. J Neurol Neurosurg Psychiatry 42:924, 1979.
11. Demeule M, Shedid D, Beaulieu E, et al: Expression of multidrug-resistance P-glycoprotein (MDR1) in human brain tumors. Int J Cancer 93:62, 2001.
12. Andrews D, Das R, Kim S, et al: Technetium-MIBI as a glioma imaging agent for the assessment of multi-drug resistance. Neurosurgery 40:1323, 1997.